NeuroQure Launches First-Ever Functional Biophysical Marker Test for Autism, Transforming Early Autism Risk Diagnosis

ASD Insight Test is a Critical Step in Redefining Autism as a Biologically Measurable Condition IRVINE, Calif.–(BUSINESS WIRE)–#AutismAwareness—NeuroQure, a pioneering leader in neurological diagnostics, announces the launch of ASD Insight, a first-of-its-kind test designed to identify autism risk as early as birth. Representing a critical step in redefining autism as a biologically measurable condition, ASD … [Read more…]

Definium Therapeutics Introduces Rerouting Minds, an Educational Campaign Exploring the Potential of Pharmaceutical Lysergide (LSD) in Mental Health Care

Rerouting Minds is designed to increase understanding of pharmaceutical lysergide (LSD) and the role of rigorous psychedelic research in addressing unmet needs in severe mental health disorders NEW YORK–(BUSINESS WIRE)–Definium Therapeutics, Inc. (formerly Mind Medicine (MindMed) Inc.), a late-stage clinical biopharmaceutical company developing a new generation of therapeutics intended to address underlying causes of psychiatric … [Read more…]

ImmunityBio Advances Regulatory Discussions with FDA on Potential Resubmission Path for ANKTIVA® in BCG-Unresponsive Papillary Bladder Cancer

Following discussions with the U.S. FDA, the Agency recommended that the Company submit additional information for its evaluation of this information to potentially support a resubmission of the sBLA for BCG-unresponsive papillary NMIBC The additional information does not include the initiation or design of any new clinical trials, and the Company will provide the requested … [Read more…]

D-Lysine Monohydrochloride (CAS 7274-88-6) Industry Research 2025: Global Market Trends 2019-2024 and Forecasts 2025-2029 – Applications, Manufacturing Method, Patents, Suppliers, Prices, End-users – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “D-Lysine Monohydrochloride (CAS 7274-88-6) Industry Research 2025: Global and Regional Market Trends 2019-2024 and Forecast to 2029” report has been added to ResearchAndMarkets.com’s offering. This report on D-Lysine monohydrochloride provides comprehensive insights, including general information, synonyms, chemical composition, safety, hazards, handling, storage, and toxicological and ecological details, along with transport information. This in-depth … [Read more…]

Serenity Mental Health Centers Offers Breakthrough Ketamine Treatment in Nocatee

Clinic may provide effective ketamine therapy for those who haven’t responded to medication NOCATEE, Fla.–(BUSINESS WIRE)–Serenity Mental Health Centers, a leader in psychiatric care and one of the fastest growing mental health providers in the nation, today announced the expansion of its ketamine treatment in Nocatee. Serenity’s board-certified psychiatrists and psychiatric mental health nurse practitioners … [Read more…]

Wellpoint DC is the First Medicaid Plan in D.C. to Earn NCQA Health Plan, Health Outcomes and Community-Focused Care Accreditations

WASHINGTON–(BUSINESS WIRE)–#CommunityCare–Wellpoint DC (formerly Amerigroup District of Columbia) is starting the new year by announcing it has been awarded NCQA Health Outcomes Accreditation and NCQA Community-Focused Care Accreditation—formerly Health Equity Accreditation and Health Equity Accreditation Plus—for its Medicaid health plan. Combined with its NCQA Health Plan Accreditation earned in October 2025, this distinction makes Wellpoint … [Read more…]

Alta Semper Signs Definitive Agreements to Acquire a Majority Stake in Nature’s Rule, a MENA-Focused Leader in Dietary Supplements and Sports Nutrition

LONDON & CAIRO–(BUSINESS WIRE)–Alta Semper, a London-based private equity firm focused on healthcare and consumer investments across growth markets, today announced that it has signed definitive agreements to acquire a majority stake in Nature’s Rule, a leading sports nutrition and dietary supplements company headquartered in the UAE, with an established manufacturing presence in Egypt. The … [Read more…]

Median Technologies Reports Landmark 2025 Performance With Major Regulatory and Commercial Milestones Ahead in 2026

Record iCRO bookings in 2025; order backlog at an all-time high of €76.6 million despite negative forex impact of € (6.5) million 2025 revenue of €23.5 million, up 2.6% vs 2024 despite negative forex impact of € (0.8) million FDA decision for eyonis® LCS expected in the coming weeks; CE marking anticipated in Q2 2026 … [Read more…]

Organon Announces US Food and Drug Administration Approval of Supplemental New Drug Application Extending Duration of Use of NEXPLANON® (etonogestrel implant) 68 mg Radiopaque

JERSEY CITY, N.J.–(BUSINESS WIRE)–Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, announced today that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for NEXPLANON® (etonogestrel implant), which is indicated for use by women of reproductive … [Read more…]

Bloom: Celebrating AHF’s Activism Through Augmented Reality and Art

2 Night Only Art Exhibition in Hollywood, January 20 and 21, 6:00 p.m. – 9:00 p.m. LOS ANGELES–(BUSINESS WIRE)–“Bloom,” a multi-sensory art experience that converts two physical murals into living, breathing works of art, will land for a two night only exhibition in Hollywood, California, on Tuesday and Wednesday, January 20th and 21st. Created in … [Read more…]